-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

617. Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis: Poster II

Acute Myeloid Leukemia: Biology, Cytogenetics and Molecular Markers in Diagnosis and Prognosis Program: Oral and Poster Abstracts
Type: Poster
Sunday, December 6, 2015: 6:00 PM-8:00 PM
Hall A, Level 2 (Orange County Convention Center)

Thomas Cluzeau, MD, PhD1,2*, Orianne Wagner-Ballon3*, Thomas Boyer4*, Estelle Guerin5*, Emmanuel Benayoun3*, Daniel Lusina6*, Isabelle Garcia7*, Claude Gardin8*, Pierre Fenaux, MD, PhD9, Cecile Pautas10*, Bruno Quesnel, MD, PhD11, Dominique Bordessoule12, Christine Terré13*, Xavier Thomas, MD, PhD14, Sylvie Castaigne15, Aline Renneville16*, Claude Preudhomme4 and Herve Dombret, MD17

1INSERM U1065, Centre Mediterraneen de Medecine Moleculaire, Nice, France
2Hematology, Saint Louis Hospital, Paris, France
3Hematology Laboratory, Henri Mondor Hospital, Creteil, France
4Hematology Laboratory, CHRU Lille, Lille, France
5Hematology Laboratory, Dupuytren Hospital, Limoges, France
6Hematology Laboratory, CHU Avicenne, Paris, France
7Hematology Laboratory, CH Versailles, Versailles, France
8Hematology, Hopital Avicenne, Bobigny, France
9Service d'Hématologie Séniors, Hôpital Saint-Louis, Université Paris 7, Paris, France
10Hematology Department, Henri Mondor Hospital, Creteil, France
11Service des Maladies du Sang, CHU Lille, Lille, France
12Hematologie Clinique, CHU de Limoges, Limoges, France
13Hematology Laboratory, CH, Versailles, France
14CHU, Lyon, France
15Dept. Hematologie, Hopital Mignot, Le Chesnay, France
16Hematology Laboratory, CHRU, Lille, France
17Hopital Saint Louis, Paris, France

Megan Othus, PhD1*, Brent L. Wood, MD, PhD2, Elihu H. Estey, MD3,4*, Stephen Petersdorf, MD5, Frederick R. Appelbaum, MD1,6, Harry P. Erba, MD, PhD7 and Roland B. Walter, MD, PhD, MS3,8,9

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Department of Laboratory Medicine/Division of Hematopathology, University of Washington, Seattle, WA
3Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
4Division of Hematology, University of Washington, Seattle, WA
5Seattle Cancer Care Alliance, Seattle, WA
6University of Washington, Seattle, WA
7Internal Medicine, Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
8Division of Hematology/Department of Medicine, University of Washington, Seattle, WA
9Department of Epidemiology, University of Washington, Seattle, WA

George S. Laszlo, PhD1*, Todd A. Alonzo, PhD2,3, Chelsea J. Gudgeon, BS1*, Kimberly H. Harrington, BS1*, Alex Kentsis, MD, PhD4, Robert B. Gerbing, MA3*, Yi-Cheng Wang, MS3*, Rhonda E. Ries, MA1*, Susana C. Raimondi, PhD3,5, Betsy A. Hirsch, PhD3,6*, Alan S. Gamis, MD, MPH3,7, Soheil Meshinchi, MD, PhD1,3 and Roland B. Walter, MD, PhD, MS1,8,9

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Keck School of Medicine, University of Southern California, Los Angeles, CA
3Children's Oncology Group, Monrovia, CA
4Memorial Sloan Kettering Cancer Center, New York, NY
5Department of Pathology, St. Jude Children's Research Hospital, Memphis, TN
6University of Minnesota, Minneapolis, MN
7Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
8Division of Hematology/Department of Medicine, University of Washington, Seattle, WA
9Department of Epidemiology, University of Washington, Seattle, WA

Daisuke Araki, MD1*, Brent L Wood, MD, PhD2, Megan Othus, PhD3*, Jerald P. Radich, MD4,5, Anna B. Halpern, MD6, Yi Zhou, MD, PhD7*, Marco Mielcarek, MD4,8, Elihu H. Estey, MD4,9*, Frederick R. Appelbaum, MD3,10 and Roland B. Walter, MD, PhD, MS4,11,12

1Department of Medicine, University of Washington, Seattle, WA
2Department of Laboratory Medicine, University of Washington, Seattle, WA
3Fred Hutchinson Cancer Research Center, Seattle, WA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Department of Medicine/Division of Medical Oncology, University of Washington, Seattle, WA
6Hematology/Oncology Fellowship Program, University of Washington/Fred Hutchinson Cancer Research Center, Seattle, WA
7Department of Laboratory Medicine/Division of Hematopathology, University of Washington, Seattle, WA
8Department of Medicine/ Division of Medical Oncology, University of Washington, Seattle, WA
9Division of Hematology, University of Washington, Seattle, WA
10University of Washington, Seattle, WA
11Department of Medicine/Division of Hematology, University of Washington, Seattle, WA
12Department of Epidemiology, University of Washington, Seattle, WA

Katerina Kuzelova, PhD1*, Barbora Brodská, PhD1*, Jana Marková1*, Grzegorz Helbig, MD, PhD2*, Slawomira Kyrcz-Krzemien, MD, PhD2 and Petr Cetkovsky, MD, MBA, PhD1*

1Institute of Hematology and Blood Transfusion, Prague, Czech Republic
2Department of Hematology and Bone Marrow Transplantation, Medical University of Silesia, Katowice, Poland

Madlen Jentzsch, MD*, Luba Schuhmann*, Marius Bill, MD PhD*, Sabine Leiblein, PhD*, Ulrike Bergmann*, Martina Pless*, Karoline Schubert*, Laura Katharina Schmalbrock, MD*, Juliane Grimm*, Maria Knyrim*, Wolfram Poenisch, MD*, Georg-Nikolaus Franke, MD*, Vladan Vucinic, MD*, Michael Cross, PhD*, Gerhard Behre, MD*, Dietger Niederwieser, MD and Sebastian Schwind, MD

Hematology and Oncology, University of Leipzig, Leipzig, Germany

Peak-Ling Lee1*, Benedict Yan, MBBS, FRCPath1*, Chin-Hin Ng, MD, MRCP, FRCPATH2*, Kenneth Hon-Kim Ban, MD, PhD3*, Wee-Joo Chng, MBBS, MRCP, FRCPath, PhD3,4,5 and Evelyn Siew-Chuan Koay, FRCPath, PhD1,3*

1National University Hospital, National University Health System, Singapore, Singapore
2Department of Haematology-Oncology, National University Cancer Institute of Singapore, Singapore, Singapore
3Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
4National University Cancer Institute, National University Health System, Singapore, Singapore
5Cancer Science Institute, National University of Singapore, Singapore, Singapore

Norio Shiba, MD, PhD1*, Kenichi Yoshida, MD, Ph.D.2*, Yuichi Shiraishi, MD, Ph.D.3*, Yusuke Hara, MD1*, Genki Yamato, MD1*, Taeko Kaburaki4*, Masashi Sanada, MD, Ph.D.5*, Kentaro Oki, MD, PhD6*, Daisuke Tomizawa, MD, PhD7, Manabu Sotomatsu8*, Hirokazu Arakawa9*, Keizo Horibe, MD, PhD10, Myoung-Ja PARK11*, Takashi Taga, MD, PhD12*, Souichi Adachi, MD, PhD13, Akio Tawa, MD, PhD14*, Satoru Miyano, MD, Ph.D.3*, Seishi Ogawa, MD, Ph.D.2 and Yasuhide Hayashi, MD, PhD15

1Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
2Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan
3Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan
4Gunma Unversity Graduste School of Medicine, Maebashi, Japan
5Department of Advanced Diagnosis, Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
6Gunma Children's Medical Center, Shibukawa, Japan
7Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
8Hematology/Oncology, Gunma Children's Medical Center, shibukawa, Japan
9Pediatrics, Gunma Unversity Graduste School of Medicine, Maebashi, Japan
10Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
11Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
12Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
13Department of Human Health Sciences, Kyoto University, Kyoto, Japan
14Department of Pediatrics, National Hospital Organization, Osaka National Hospital, Osaka, Japan
15Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan

Fabiana Ostronoff, MD1, Todd A. Alonzo, PhD2, Megan Othus, PhD3*, Matthew A. Kutny, MD4, Robert B. Gerbing, MA5*, Jerald P. Radich, MD1, Harry P. Erba, MD, PhD6, Frederick R. Appelbaum, MD7, E. Anders Kolb, MD8, Alan S. Gamis, MD, MPH9, Derek L. Stirewalt, MD10 and Soheil Meshinchi, MD, PhD1

1Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
2Keck School of Medicine, University of Southern California, Los Angeles, CA
3SWOG Statistical Center, Seattle, WA
4University of Alabama at Birmingham, Birmingham
5Children's Oncology Group, Monrovia, CA
6Internal Medicine, Hematology/Oncology, University of Alabama at Birmingham, Birmingham, AL
7Fred Hutchinson Cancer Research Center, Seattle, WA
8Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
9Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO
10Fred Hutchinson Cancer Research Ctr., Seattle, WA

Mauricette Michallet, MD, PhD1, Mohamad Sobh, PharmD1*, Hélène Labussière-wallet, MD1*, Marie Balsat, MD1*, Caroline Lejeune, MD1*, Isabelle Mollet, Tech.2*, Philippe Moskovtchenko, Tech.2*, Xavier Thomas1, Fiorenza Barraco, MD1*, Valérie Mialou, Tech.2*, Valérie Dubois, MD2* and Franck E. Nicolini, MD, PhD1

1Hematology department 1G, Centre Hospitalier Lyon Sud, Pierre Bénite, France
2Histocompatibility laboratory, EFS Rhône Alpes, Lyon, France

Claudia Haferlach, MD1, Niroshan Nadarajah, M.Sc.1*, Annette Fasan, PhD1*, Karolína Perglerová2*, Wolfgang Kern, MD1, Susanne Schnittger, PhD1 and Torsten Haferlach1

1MLL Munich Leukemia Laboratory, Munich, Germany
2MLL2 s.r.o., Praha, Czech Republic

Farhad Ravandi, MD1, Jorgensen L Jeffrey, MD, PhD2*, Elias J Jabbour, MD1, Gautam Borthakur, MD1, Tapan Kadia, MD1, Stefan Faderl, MD3*, Sherry Pierce, BSN, BA1*, Mark Brandt, BS4*, Sa A. Wang, MD5*, Sergej Konoplev, MD, PhD6, Naval Daver, MD1, Naveen Pemmaraju, MD1, Guillermo Garcia-Manero, MD7, Michael Andreeff, MD, PhD8, Marina Konopleva, MD, PhD9, Jorge E. Cortes, MD4 and Hagop M. Kantarjian, MD1

1Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
2Hematopathology, University of Texas - MD Anderson Cancer Center, Houston, TX
3John Theurer Cancer Center at Hackensack University Medical Center, Hackensack, NJ
4Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
5Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
6Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX
8Section of Molecular Hematology and Therapy, Leukemia Department, UT MD Anderson Cancer Center, Houston, TX
9Section of Molecular Hematology and Therapy, Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Bernhard Reis, Ph.D.1*, Lori Jukofsky2*, Gong Chen, Ph.D.2*, Giovanni Martinelli3, Hua Zhong, Ph.D.2*, Venus So, Ph.D.2*, Michael J. Dickinson, MBBS, FRACP, FRCPA4, Mark W. Drummond, PhD, MD5*, Sarit E. Assouline, MD MSc6, Maneja Hashemyan2*, Michel Theron, Ph.D.1*, Steven Blotner, Ph.D.2*, Je-Hwan Lee, MD, PhD7, Margaret Kasner, M.D.8, Sung-Soo Yoon9, Ruediger Rueger, M.D.10*, Karen Seiter, MD11, Steven Middleton, PhD2*, Kevin R. Kelly, M.D., Ph.D.12, Norbert Vey13, Karen W.L. Yee, MD14, Gwen Nichols, MD15, Lin-Chi Chen, MD, PhD2 and William E. Pierceall, PhD2

1Roche Pharma Research & Early Development, Roche Innovation Center Basel, Basel, Switzerland
2Roche Pharma Research & Early Development, Roche Innovation Center New York, New York, NY
3"Seràgnoli" Institute of Hematology, University of Bologna, Bologna, Italy
4Department of Haematology, Peter MacCallum Cancer Centre, Melbourne, Australia
5Beatson West of Scotland Cancer Centre, NHS Greater Glasgow and Clyde, Glasgow, United Kingdom
6Jewish General Hospital, Montreal, QC, Canada
7Department of Hematology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, South Korea
8Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA
9Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
10Roche Pharma Research & Early Development, Roche Innovation Center Penzberg, Penzberg, Germany
11New York Medical College, Valhalla, NY
12University of Southern California Keck School of Medicine, Los Angeles, CA
13Hematology, Institut Paoli-Calmettes, Marseille, France
14Princess Margaret Cancer Center, Toronto, ON, Canada
15Roche Pharma Research & Early Development, Roche Innovation Center, New York, NY

Marie Balsat, MD1*, Aline Renneville2*, Xavier Thomas1, Alice Marceau2*, Stéphane De Botton3*, Olivier Nibourel2*, Emmanuel Raffoux4*, Céline Rodriguez2*, Jean-Michel Cayuela4*, Sandrine Hayette5*, Christine Terré6*, Karine Celli-Lebras7*, Hervé Dombret4, Claude Preudhomme2 and Nicolas Boissel4

1Hematology, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
2Hematology Laboratory, CHRU, Lille, France
3Hematology, Gustave Roussy, Villejuif, France
4Hematology, Hôpital Saint-Louis, Paris, France
5Hematology Laboratory, Centre Hospitalier Lyon-Sud, Pierre Bénite, France
6Hematology Laboratory, Centre Hospitalier, Versailles, France
7ALFA Coordination, Hôpital Saint-Louis, Paris, France

Papagudi Ganesan Subramanian, MD1*, Nikhil Patkar, MD1*, Prashant Tembhare, MD,1*, Yajamanam Badrinath2*, Sitaram G Ghogale, BSc2*, Sumeet Gujral, MD3 and Navin Khattry, MD DM4*

1Hematopathology Laboratory, Tata Memorial Centre, Mumbai, India
2Hematopathology Laboratory, Tata Memorial Hospital, Mumbai, India
3Department of Pathology, Tata Memorial Centre, Mumbai, India
4Tata Memorial Center, ACTREC, Mumbai, India

Yusuke Hara, MD1,2*, Genki Yamato, MD1,2*, Norio Shiba, MD, PhD1,2*, Kentaro Ohki, MD, PhD2,3*, Myoung-Ja Park, MD, PhD2*, Daisuke Tomizawa, MD, PhD4, Tomohiko Taki, MD, PhD5, Takashi Taga, MD, PhD6*, Hirokazu Arakawa, MD, PhD1*, Akio Tawa, MD, PhD7*, Keizo Horibe, MD, PhD8, Souichi Adachi, MD, PhD9 and Yasuhide Hayashi, MD, PhD2,10

1Department of Pediatrics, Gunma University Graduate School of Medicine, Maebashi, Japan
2Department of Hematology/Oncology, Gunma Children's Medical Center, Shibukawa, Japan
3Departmentof Pediatric Hematology and Oncology Research, National Center for Child Health and Development, Tokyo, Japan
4Division of Leukemia and Lymphoma, Children’s Cancer Center, National Center for Child Health and Development, Tokyo, Japan
5Department of Molecular Diagnostics and Therapeutics, Kyoto Prefectural University of Medicine, Kyoto, Japan
6Department of Pediatrics, Shiga University of Medical Science, Otsu, Japan
7Department of Pediatrics, National Hospital Organization, Osaka National Hospital, Osaka, Japan
8Clinical Research Center, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
9Department of Human Health Sciences, Kyoto University, Kyoto, Japan
10Japanese Red Cross Gunma Blood Center, Maebashi, Japan

Dirkje W. Hanekamp1*, Barbara Denys2*, Gertjan J.L. Kaspers, MD, PhD3, Jeroen G. te Marvelde4*, Gerrit Jan Schuurhuis, PhD1, Valerie De Haas, MD, PhD5, Barbara De Moerloose, MD, PhD6*, Eveline S. de Bont7, Anja de Jong5*, Jan Philippé, MD, PhD2*, Jacqueline Cloos, PhD1,3* and Vincent H.J. van der Velden, PhD4*

1Department of Hematology, VU University Medical Center, Amsterdam, Netherlands
2Department of Clinical Biology, Microbiology and Immunology, Ghent University, Ghent, Belgium
3Department of Pediatric Oncology/Hematology, VU University Medical Center, Amsterdam, Netherlands
4Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, Netherlands
5Dutch Childhood Oncology Group, The Hague, Netherlands
6Department of Pediatrics, Ghent University, Ghent, Belgium
7Department of Pediatric Oncology/Hematology, Beatrix Children’s Hospital, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

Frauke Theis1*, Peter Paschka, MD1, Daniela Weber1*, Verena I. Gaidzik, MD1*, Lars Bullinger, MD1, Maria-Veronica Teleanu, MD1*, Gudrun Göhring, MD2*, Helmut R. Salih, MD3, Andrea Kündgen4*, Hans-Juergen Salwender, MD5*, Joerg Westermann, MD6*, Walter Fiedler, MD7, Katharina Götze8, Heinz-August Horst, MD, PhD9, Gerald G Wulf, MD10, Michael Luebbert, MD11*, Dominik Wolf, MD12*, Thomas Kindler, MD13*, Mark Ringhoffer, MD14*, Doris Kraemer, MD15*, Jürgen Krauter, MD16*, Felicitas Thol, MD17, Michael Heuser, M.D.17, Arnold Ganser, M.D.17, Hartmut Döhner, MD1, Richard F. Schlenk, MD1 and Konstanze Döhner, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
3Department of Hematology and Oncology, Eberhard Karls University, Tuebingen, Germany
4Department of Hematology, Oncology and Clinical Immunology, Heinrich-Heine-University Düsseldorf, Düsseldorf, Germany
5Asklepios Hospital Hamburg Altona, Hamburg, Germany
6Department of Hematology, Oncology and Tumor Immunology, Charité-University Medicine Berlin, Campus Virchow Klinikum, Berlin, Germany
7Hubertus Wald University Cancer Center Department of Oncology and Hematology, University Medical Center Eppendorf, Hamburg, Germany
8Department of Internal Medicine III, University Hospital of Munich, Munich, Germany
9Department of Internal Medicine II, University Hospital Schleswig Holstein, Campus Kiel, Kiel, Germany
10Department of Hematology and Oncology, University Hospital of Göttingen, Göttingen, Germany
11Department of Medicine, Devision of Hematology and Oncology, University Hospital of Freiburg, Freiburg, Germany
12Department of Internal Medicine III, Oncology, Hematology and Rheumatology, University Hospital Bonn, Bonn, Germany
13University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
14Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany
15Department of Oncology and Hematology, Klinikum Oldenburg, Oldenburg, Germany
16Department of Internal Medicine III, Municipal Hospital of Braunschweig, Braunschweig, Germany
17Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany

Mridul Agrawal, MD1*, Andrea Corbacioglu, PhD1*, Nikolaus Jahn, MD1*, Lars Bullinger, MD1, Maria-Veronica Teleanu, MD1*, Verena I. Gaidzik, MD1*, Daniela Weber1*, Gudrun Göhring, MD2*, Michael Luebbert, MD3*, Walter Fiedler, MD4, Peter Brossart, MD5, Thomas Kindler, MD6*, Markus Radsak, MD6*, Mark Ringhoffer, MD7*, Katharina S. Götze, MD8, Richard Greil, MD9, Felicitas Thol, MD10, Michael Heuser, MD10, Arnold Ganser, M.D.10, Richard F. Schlenk, MD11, Hartmut Döhner, MD1*, Peter Paschka, MD1 and Konstanze Döhner, MD1

1Department of Internal Medicine III, University Hospital of Ulm, Ulm, Germany
2Institute of Cell and Molecular Pathology, Hannover Medical School, Hannover, Germany
3Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
4Department of Oncology, Hematology and Bone Marrow Transplantation with Section Pneumology, Hubertus Wald University Cancer Center, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
5Internal Medicine III, Oncology, Hematology and Rheumatology, University Clinic Bonn, Bonn, Germany
6University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany
7Department of Internal Medicine III, Municipal Hospital of Karlsruhe, Karlsruhe, Germany
8III. Department of Medicine, Hematology and Medical Oncology, Technical University of Munich, Munich, Germany
93rd Medical Department with Hematology and Medical Oncology, Hemostaseology, Rheumatology and Infectious Diseases, Laboratory for Immunological and Molecular Cancer Research, Oncologic Center, Paracelsus Medical University Hospital Salzburg, and Center for Clinical Cancer and Immunology Trials at Salzburg Cancer Research Institute, Salzburg, Austria
10Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany
11University Hospital of Ulm, Ulm, Germany

Jason E. Farrar, M.D.1, Todd A. Alonzo, PhD2,3, Rhonda E. Ries, MA4*, Robert B. Gerbing, MA3*, Jaime M. Guidry Auvil, PhD5*, Tanja M. Davidsen, PhD5*, Patee Gesuwan5*, Leandro C. Hermida5*, Marco A Marra, PhD6, Andrew J. Mungall, PhD6, Karen Mungall, PhD6*, Yussanne Ma, PhD6*, William Long, PhD6*, Stuart Zong6*, E. Anders Kolb, MD7, Malcolm A. Smith, MD, PhD8, Daniela S. Gerhard, PhD5*, Alan S. Gamis, MD, MPH9 and Soheil Meshinchi, MD, PhD4

1Department of Pediatics/Hematology Oncology Section, University of Arkansas for Medical Sciences, Little Rock, AR
2Keck School of Medicine, University of Southern California, Los Angeles, CA
3Children's Oncology Group, Monrovia, CA
4Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
5Office of Cancer Genomics, National Cancer Institute, Bethesda, MD
6Michael Smith Genome Sciences Centre, British Columbia Cancer Agency, Vancouver, BC, Canada
7Nemours Center for Cancer and Blood Disorders, Alfred I. duPont Hospital for Children, Wilmington, DE
8Cancer Therapy Evaluation Program, National Cancer Institute, Bethesda, MD
9Division of Hematology/Oncology/Bone Marrow Transplantation, Children's Mercy Hospitals and Clinics, Kansas City, MO

Louise Roulin1*, Ashfaq Ali1*, Aline Masse2*, Marie-Magdelaine Coudé2*, Dominique Bluteau1*, Thorsten Braun, MD, PhD2,3*, Jeannig Berrou2*, Olivier Bluteau1*, Marc Delord4*, Maria Eugenia Riveiro5*, Patrice EDOUARD Herait, MD6*, Jean Soulier, MD, PhD7, André Baruchel, MD2,8, Claude Gardin, MD2,9*, Hervé Dombret2,10 and Raphaël Itzykson, MD, PhD1,11

1UMR7212/U944, Institut National de la Santé et de la Recherche Médicale, Saint-Louis Institute, University Paris 7, Paris, France
2Laboratoire de Transfert des Leucémies, Institut Universitaire d'Hématologie, University Paris VII, Paris, France
3Clinical Hematology, CHU Avicenne, Bobigny, France
4Bioinformatics, Institut Universitaire d'Hématologie, University Paris VII, Paris, France
5OTD, Clichy, France
6ONCOETHIX, SOISY SOUS MONTMORENCY, France
7Institute of hematology, University Paris-Diderot, Paris, France
8Department of Hematology, Hopital Robert Debré, Paris, France
9Hematology Department, Avicenne Hospital, APHP, University Paris 13, Bobigny, France
10Leukemia Unit, Hematology department, Hôpital Saint-Louis, Paris, France
11Hematology Department, Saint-Louis Hospital, University Paris 7, Paris, France

Marcus Celik Hansen, MSc in Biomedical Engineering1*, Sadudee Chotirat, MD2*, Chirayu Udomsakdi Auewarakul, MD, PhD, Professor3* and Peter Hokland, MD D.Med.Sci, Professor1

1Department of Hematology, Aarhus University Hospital, Aarhus, Denmark
2Leukemia Research Laboratory, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand
3Chulabhorn Cancer Centre and Faculty of Medicine, Siriraj Hospital, Mahidol University, Bangkok, Thailand

Krzysztof Giannopoulos, MD, PhD1,2*, Malgorzata Zajac, PhD1,3*, Olga Jankowska-Lecka, PhD4*, Joanna Zaleska1*, Joanna Purkot1*, Tomasz Gromek, MD4*, Maria Soroka-Wojtaszko, MD, PhD4*, Aneta Szudy-Szczyrek, MD4*, Marek Hus, MD, PhD4* and Lars Bullinger, MD5

1Department of Experimental Hematooncology, Medical University of Lublin, Lublin, Poland
2Department of Hematology, St. John’s Cancer Center, Lublin, Poland
3Postgraduate School of Molecular Medicine of Warsaw, Warsaw, Poland
4Department of Hematooncology and Bone Marrow Transplantation Unit, Medical University of Lublin, Lublin, Poland
5University of Ulm, Ulm, Germany

Marlise R. Luskin, MD1, Phyllis Gimotty, PhD2*, Catherine Smith3*, Alison Loren, MD, MS4, Maria Figueroa, MD5*, Jenna Harrison3*, Zhuoxin Sun, PhD6*, Martin S Tallman, MD7, Elisabeth Paietta, PhD8, Mark R Litzow, MD9, Ross L. Levine, MD10, Hugo F. Fernandez, M.D.11, Selina Luger, MD12, Martin Carroll, MD12, Stephen Master, MD, PhD13* and Gerald Wertheim, MD, PhD14*

1Brigham and Women's Hospital, Boston, MA
2Department of Biostatistics & Epidemiology, University of Pennsylvania, Philadelphia, PA
3Department of Pathology, Children's Hospital of Philadelphia, Philadelphia, PA
4Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA
5University of Michigan Medical School, Ann Arbor, MI
6Dana-Farber Cancer Institute, Boston, MA
7Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
8Cancer Center, The North Division of Montefiore Medical Center, Bronx, NY
9Division of Hematology, Mayo Clinic, Rochester, MN
10Memorial Sloan Kettering Cancer Center, New York, NY
11Blood and Marrow Transplantation, H. Lee Moffitt Cancer Center, Tampa, FL
12Division of Hematology & Oncology, University of Pennsylvania, Philadelphia, PA
13Department of Pathology & Laboratory Medicine, Weill Cornell Medical College, New York, NY
14Department of Pathology & Laboratory Medicine, University of Pennsylvania, Philadelphia, PA

Jessica Leonard, MD1, Jennifer Dunlap, MD2, Tanaya L Neff1*, Andrea Warrick1*, Fei Yang3*, Richard D. Press, MD, PhD4, Brian J. Druker, MD5 and Elie Traer, M.D., Ph.D.6

1Oregon Health and Science University, Portland, OR
2Department of Pathology, Oregon Health & Science University, Portland, OR
3Oregon Health & Science University, Portland, OR
4Prof. & Dir. of Molecular Pathology, Oregon Health & Science Univ., Portland, OR
5Howard Hughes Medical Institute, Oregon Health & Science University, Knight Cancer Institute, Portland, OR
6Division of Hematology and Medical Oncology, Oregon Health & Science University, Knight Cancer Institute, Portland, OR

Thomas Köhnke, MD1,2*, Sandra Rechkemmer1*, Veit Leonhard Bücklein, MD1,2*, Kristina Pfannes, PhD1*, Michael Fiegl, MD1*, Karsten Spiekermann, MD1, Wolfgang Hiddemann, MD3 and Marion Subklewe, MD1,2

1Department of Internal Medicine III, Klinikum der Universität München, Munich, Germany
2Clinical Cooperation Group Immunotherapy at the Helmholtz Zentrum München, Munich, Germany
3Department of Internal Medicine III, University Hospital Grosshadern, Ludwig-Maximilians-Universität, Munich, Germany

Srikanth Gottipati, PhD1*, Shashank Rohatagi, PhD1*, Woonbok Chung, PhD2*, Pietro Taverna, PhD3*, Hagop M. Kantarjian, MD4, Gail J. Roboz, MD5, Patricia L. Kropf, MD6, Mohammad Azab, MD3 and Jean-Pierre Issa, MD2

1Otsuka Pharmaceutical Development & Commercialization, Inc., Princeton, NJ
2Fels Institute, Temple University, Philadelphia, PA
3Astex Pharmaceuticals, Inc., Pleasanton, CA
4Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
5Division of Hematology and Oncology, Department of Medicine, Weill Cornell Medical College, New York, NY
6Fox Chase Cancer Center, Philadelphia, PA

Daeyoon Kim1*, Youngil Koh, MD1,2*, Jeonghwan Youk2*, Kwang-Sung Ahn, PhD3*, Hwi-Joong Yoon, M.D., Ph.D.4, Hyun Jung Lee, MD5*, Hyo Jung Kim, MD, PhD6*, Junglim Lee, MD7 and Sung-Soo Yoon, MD PhD1,2

1Cancer Research Institute, Seoul National University College of Medicine, Seoul, South Korea
2Department of Internal Medicine, Seoul National University Hospital, Seoul, South Korea
3Functional Genome Institute, PDXen Biosystems Inc., Seoul, South Korea
4Kyung Hee University College of Medicine, Seoul, South Korea
5Department of Internal Medicine, Dongguk University Ilsan Hospital, Ilsan, South Korea
6Department of Internal Medicine, Hallym University College of Medicine, Anyang, South Korea
7Daegu Fatima Hospital Public Cord Blood Bank, Daegu, South Korea

Taehyung Simon Kim, PhD1,2*, Zhaolei Zhang, PhD1,3,4*, Marc Tyndel1,5*, Jae-Sook Ahn, MD, PhD6*, Yeo-Kyeoung Kim, M.D., Ph.D.6, Seung Hyun Choi, PhD7*, Hyeoung-Joon Kim, MD, PhD6,7, Moses Lee8*, Murim Choi8*, Jeffrey H. Lipton, MD, PhD9 and Dennis Dong Hwan Kim, MD, PhD10

1Department of Computer Science, University of Toronto, Toronto, Canada
2The Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Canada
3The Donnelly Centre, University of Toronto, Toronto, Canada
4Department of Molecular Genetics, University of Toronto, Toronto, Canada
5The Edward S. Rogers Sr. Department of Electrical and Computer Engineering, University of Toronto, Toronto, Canada
6Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, South Korea
7Genomic Research Center for Hematopoietic Diseases, Chonnam National University Hwasun Hospital, Hwasun, South Korea
8Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul, South Korea
9Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
10Department of Medical Oncology & Hematology, Princess Margaret Cancer Centre, University of Toronto, Toronto, ON, Canada

Andrew M. Brunner, MD1,2, Donna S Neuberg, ScD3, Seth A. Wander, MD, PhD1, Hossein Sadrzadeh, MD4, Karen K. Ballen, MD1, Philip C. Amrein, MD1, Gabriela S. Hobbs, MD1, Yi-Bin Chen, MD1, Ashley M. Perry, BS1*, Christelle Joseph1*, Meghan E. Burke1*, Aura Y Ramos1*, Regina Silver1*, Ilene Galinsky, ANP5, Sophia Adamia, PhD2, Darrell Borger, PhD1*, Anthony J Iafrate, MD, PhD1*, Richard M. Stone, MD5 and Amir T. Fathi, MD1

1Massachusetts General Hospital, Boston, MA
2Dana-Farber Cancer Institute, Boston, MA
3Department of Biostatistics and Computational Biology, Dana-Farber Cancer Institute, Boston, MA
4Capital Health system, Trenton, NJ
5Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA

Jasmijn de Rooij, MD1*, Riccardo Masetti, MD2*, Marry M. van den Heuvel-Eibrink, MD, PhD1,3*, Jean-Michel Cayuela4*, Jan Trka5, Dirk Reinhardt, MD6, Edwin Sonneveld, PhD7*, Todd A. Alonzo, PhD8, Maarten Fornerod1*, Martin Zimmermann9*, Martina Pigazzi, PhD10*, Rob Pieters, MD, PhD3, Soheil Meshinchi, MD, PhD11, C. Michel Zwaan1 and Franco Locatelli12

1Pediatric Oncology/Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, Netherlands
2Pediatric Oncology and Hematology, University of Bologna, Bologna, Italy
3Princess Máxima Center for Pediatric Oncology, Utrecht, Netherlands
4Hematology, Hôpital Saint-Louis, Paris, France
5Department of Paediatric Haematology and Oncology, 2nd School of Medicine, Charles University, Prague, Czech Republic
6AML-BFM Study Group, Pediatric Hematology/Oncology, University Children’s Hospital Essen, Essen, Germany
7Dutch Childhood Oncology Group, The Hague, Netherlands
8Children's Oncology Group, Monrovia, CA
9AML-BFM Study Group, Pediatric Hematology and Oncology, Medical School Hannover, Hannover, Germany
10Woman and Child Health Department, University of Padova, Padova, Italy
11Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA
12IRCCS Ospedale Pediatrico Bambino Gesù, University of Padua, Rome, Italy

Ashvind A Prabahran, MBBS1*, Mark Tacey, BSc2,3*, Shaun Fleming, MBBS (Hons), FRACP, FRCPA4*, Danielle Strong5*, Andrew Wei, MBBS, PhD6, Courtney Tate, MBBS7*, Paula Marlton, MBBS7, Joel Wight, MBBS8*, Andrew Grigg, MBBS, MD, FRACP, FRACPA9*, Annabel Tuckfield, MBBS, FRACP, FRCPA, PhD10*, Jeff Szer, MB, BS, FRACP11, David S. Ritchie, MD, PhD11 and Lynette C.Y. Chee, MBBS, FRACP, FRCPA, PhD12

1Clinical Haematology, Royal Melbourne Hospital, Parkville, Australia
2Epicentre, Royal Melbourne Hospital, Parkville, Australia
3Epicentre, University of Melbourne, Parkville, Australia
4Department of Haematology, Alfred Hospital, Melbourne, Australia
5Medical School, Monash University, Caufield, Australia
6Haematology, The Alfred Hospital, Melbourne, Australia
7Clinical Haematology, Princess Alexandra Hospital, Brisbane, Australia
8Clinical Haematology, Austin Hospital, Heidelberg, Australia
9Austin Health, Heidelberg, Australia
10Royal Melbourne Hosp., Parkville, Australia
11Royal Melbourne Hospital, Parkville, Australia
12The Royal Melbourne Hospital, Parkville, Australia

Maria Chiara Fontana1*, Viviana Guadagnuolo, PhD2*, Cristina Papayannidis, MD, PhD3, Giorgia Simonetti, PhD2*, Antonella Padella2*, Anna Ferrari, PhD2*, Marco Manfrini, PhD3*, Italo Faria do Valle4,5*, Barbara Santacroce6*, Margherita Perricone7*, Giovanni Marconi, MD2*, Emanuela Ottaviani2*, Jelena D. Milosevic Feenstra, PhD8*, Doris Chen, PhD8*, Nicole C.C. Them8*, Simona Soverini9, Daniel Remondini, PhD5*, Gerardo Musuraca10*, Michele Cavo, MD11*, Robert Kralovics, PhD8 and Giovanni Martinelli11

1Seragnoli Institute, University of Bologna, Bologna, Italy
2University of Bologna, Bologna, Italy
3Bologna University School of Medicine, Bologna, Italy
4Ministry of Education of Brazil, CAPES Foundation, Brazilia, Brazil
5Department of Physics and Astronomy, University of Bologna, Bologna, Italy
6DIMES - Department of Experimental, Diagnostic and Specialty Medicine, Institute of Hematology, University of Bologna, Bologna, Italy
7Institute of Hematology, Bologna, Italy
8CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria
9Institute of Hematology, S.Orsola-Malpighi University Hospital, Bologna, Italy
10Istituto Scientifico Romagnolo Per Lo Studio E La Cura Dei Tumori, Meldola (FC),, Meldola, Italy
11"Seràgnoli" Institute of Hematology, University of Bologna, Bologna, Italy

Guardo Daniela, MD*, Fabio Guolo, MD*, Paola Minetto, MD*, Marino Clavio, MD*, Livia Giannoni, MD*, Elisa Coviello, MD*, Giordana Pastori, MD*, Giulia Rivoli, MD*, Filippo Ballerini, MD*, Nicoletta Colombo, PhD*, Raffaella Grasso, PhD*, Maurizio Miglino, PhD*, Roberto Massimo Lemoli, MD and Marco Gobbi, MD*

Chair of Hematology, Department of Internal Medicine (DiMI), IRCCS AOU San Martino-IST, University of Genoa, Genoa, Italy

Emily Silgard, M.S. Computational Linguistics1*, Vicky Sandhu, MD, MPH2*, Elihu H. Estey, MD3,4 and Daniel Herman, M.D., PhD4*

1Fred Hutchinson Cancer Research Center, Seattle, WA
2Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, WA
3Seattle Cancer Care Alliance, Seattle, WA
4University of Washington School of Medicine, Seattle, WA

Alyssa Carey, B.S.1*, Swati Garg1*, Megan M Cleary, B.S., B.A.1*, David K Edwards V, B.A., B.S.2, Marc Loriaux, MD, PhD1*, Shannon L Winski, PhD3*, LouAnn Cable, B.S.3*, Jeffrey W. Tyner, PhD2 and Anupriya Agarwal, PhD1

1Knight Cancer Institute, Division of Hematology and Medical Oncology, Oregon Health & Science University, Portland, OR
2Knight Cancer Institute, Department of Cell, Developmental & Cancer Biology, Oregon Health and Science University, Portland, OR
3Array BioPharma Inc., Boulder, CO

Brittany Knick Ragon, MD1, Naval Daver, MD2, Guillermo Garcia-Manero, MD2, Maro Ohanian, DO2*, Alessandra Ferrajoli, MD2, Naveen Pemmaraju, MD2, Hagop M Kantarjian, MD2 and Gautam Borthakur, MD2

1Hematology/Oncology Fellowship, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX
2Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX

Aaron C. Shaver, MD, PhD1*, Adam C. Seegmiller, MD, PhD1*, Stephen A. Strickland, MD2, Robert D. Daber, Ph.D.3*, Sanjay R. Mohan, MD2*, Paul Brent Ferrell Jr., MD4, Cindy Vnencak-Jones, Ph.D.1*, David R. Head, MD1, Annette S. Kim, MD, PhD1, Mary M. Zutter, MD1 and Michael R. Savona, MD4

1Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN
2Department of Medicine, Division of Hematology and Oncology, Vanderbilt University Medical Center, Nashville, TN
3BioReference Laboratories, Elmwood Park, NJ
4Department of Medicine, Division of Hematology/Oncology, Vanderbilt University Medical Center, Nashville, TN

Huthayfa Mujahed, MS.c1*, Deneberg Stefan1* and Soren Lehmann, MD, PhD2

1Center for Haematology and regenerative medicine, Karolinska institute, Stockholm, Sweden
2Department of Medicine, Center for Hematology and Regenerative Medicine, Karolinska Institutet, Stockholm, Sweden

Michael Boyiadzis, MD, MHSc, Chang Sook Hong, PhD* and Theresa L Whiteside, PhD*

University of Pittsburgh Cancer Institute, Pittsburgh, PA

*signifies non-member of ASH